Bingquan (Stuart) Wang, PhDDirector at Moderna Therapeutics
Bingquan (Stuart) Wang is a Director at Moderna, and has held various positions in big biotech companies including Shire, Biogen, Genzyme, etc and supported the development and validation of different biologics drug products. He received a Ph.D. in Pharmaceutics from Michael Pikal's lab at the University of Connecticut. He has more than 12 years of experience in biologics formulation, fill/finish process development, lyophilization process development and scale up, Tech Transfer, biophysical characterization, CMC regulatory filing, manufacturing process support and commercial lifecycle management. He has built lyophilization scale-down model, constructed process design space using QbD approach, and developed a scale up strategy for lyophilization in dual chamber syringe, and has been providing technical leadership to Technology Transfer to multiple CMOs and internal fill/finish sites. He has direct experience addressing review questions from regulatory agencies and has been working with several organizations to harmonize best practices in lyophilizer design and process scale up using science-based approach. He has published 3 book chapters in the protein formulations and lyophilization process development and PAT, more than 30 research papers in peer-reviewed journals, and has been invited to give numerous presentations in various international conferences.